These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 29030418)

  • 1. Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders.
    Bonnan M; Valentino R; Debeugny S; Merle H; Fergé JL; Mehdaoui H; Cabre P
    J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):346-351. PubMed ID: 29030418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange.
    Abboud H; Petrak A; Mealy M; Sasidharan S; Siddique L; Levy M
    Mult Scler; 2016 Feb; 22(2):185-92. PubMed ID: 25921047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
    J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes and predictive factors related to good outcomes in plasma exchange in severe attack of NMOSD and long extensive transverse myelitis: Case series and review of the literature.
    Aungsumart S; Apiwattanakul M
    Mult Scler Relat Disord; 2017 Apr; 13():93-97. PubMed ID: 28427710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Exchange for Neuromyelitis Optica Spectrum Disorders in Chinese Patients and Factors Predictive of Short-term Outcome.
    Jiao Y; Cui L; Zhang W; Zhang Y; Wang W; Zhang L; Tang W; Jiao J
    Clin Ther; 2018 Apr; 40(4):603-612. PubMed ID: 29606515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic indicators of improvement with therapeutic plasma exchange in pediatric demyelination.
    Savransky A; Rubstein A; Rios MH; Vergel SL; Velasquez MC; Sierra SP; Marcarian G; Alba R; Pugliese AM; Tenembaum S
    Neurology; 2019 Nov; 93(22):e2065-e2073. PubMed ID: 31645471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of plasma exchange for the treatment of optic neuritis in neuromyelitis optica spectrum disorders: A protocol for systematic review and meta-analysis.
    Han M; Chen Y; Nong L; Liu Z; Hao L; Wang Z
    Medicine (Baltimore); 2020 Jul; 99(28):e21067. PubMed ID: 32664124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX.
    Songthammawat T; Srisupa-Olan T; Siritho S; Kittisares K; Jitprapaikulsan J; Sathukitchai C; Prayoonwiwat N
    Mult Scler Relat Disord; 2020 Feb; 38():101506. PubMed ID: 31731214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective cohort study of plasma exchange in central nervous system demyelinating events in children.
    Manguinao M; Krysko KM; Maddike S; Rutatangwa A; Francisco C; Hart J; Chong J; Graves JS; Waubant E
    Mult Scler Relat Disord; 2019 Oct; 35():50-54. PubMed ID: 31319355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder.
    Yaguchi H; Sakushima K; Takahashi I; Nishimura H; Yashima-Yamada M; Nakamura M; Tsuzaka K; Maruo Y; Takahashi T; Yabe I; Sasaki H
    Intern Med; 2013; 52(9):969-72. PubMed ID: 23648715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual Outcomes Following Plasma Exchange for Optic Neuritis: An International Multicenter Retrospective Analysis of 395 Optic Neuritis Attacks.
    Chen JJ; Flanagan EP; Pittock SJ; Stern NC; Tisavipat N; Bhatti MT; Chodnicki KD; Tajfirouz DA; Jamali S; Kunchok A; Eggenberger ER; Nome MAD; Sotirchos ES; Vasileiou ES; Henderson AD; Arnold AC; Bonelli L; Moss HE; Navarro SEV; Padungkiatsagul T; Stiebel-Kalish H; Lotan I; Wilf-Yarkoni A; Danesh-Meyer H; Ivanov S; Huda S; Forcadela M; Hodge D; Poullin P; Rode J; Papeix C; Saheb S; Boudot de la Motte M; Vignal C; Hacohen Y; Pique J; Maillart E; Deschamps R; Audoin B; Marignier R
    Am J Ophthalmol; 2023 Aug; 252():213-224. PubMed ID: 36822570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder.
    Bonnan M; Valentino R; Olindo S; Mehdaoui H; Smadja D; Cabre P
    Mult Scler; 2009 Apr; 15(4):487-92. PubMed ID: 19324982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory Features.
    Altintas A; Karabudak R; Balci BP; Terzi M; Soysal A; Saip S; Tuncer Kurne A; Uygunoglu U; Nalbantoglu M; Gozubatik Celik G; Isik N; Celik Y; Gokcay F; Duman T; Boz C; Yucesan C; Mangan MS; Celebisoy N; Diker S; Colpak Isikay I; Kansu T; Siva A
    Neurologist; 2015 Oct; 20(4):61-6. PubMed ID: 26468870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
    Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
    JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma exchange for acute optic neuritis in neuromyelitis optica or neuromyelitis optica spectrum disorder: a systematic review.
    Naphattalung Y; Chuenkongkaew WL; Chirapapaisan N; Laowanapiban P; Sawangkul S
    Ann Med; 2023 Dec; 55(1):2227422. PubMed ID: 37387119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
    Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
    Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
    J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rescue effect of plasma exchange for neuromyelitis optica.
    Wang KC; Wang SJ; Lee CL; Chen SY; Tsai CP
    J Clin Neurosci; 2011 Jan; 18(1):43-6. PubMed ID: 20888238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromyelitis Optica Spectrum Disorders.
    Akaishi T; Nakashima I; Sato DK; Takahashi T; Fujihara K
    Neuroimaging Clin N Am; 2017 May; 27(2):251-265. PubMed ID: 28391784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.